![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profileg](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
Mike Thompson, MD, PhD, FASCO
@mtmdphd
Views my own. VP Clinical Partnerships @TempusAI #PrecisionMedicine #mmsm #lymsm #CCC19 @COVID19nCCC @ASCO COI: https://t.co/A6GQmWYvau
ID:190337035
https://www.linkedin.com/in/michaelthompsonmdphd/ 13-09-2010 18:03:36
143,4K Tweets
23,1K Followers
3,9K Following
Follow People
![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
Impact of extramedullary multiple myeloma [EMD] on outcomes with idecabtagene vicleucel - Saurabh Zanwar et al. #ASCO24 Abstract 7508 meetings.asco.org/abstracts-pres… #mmsm #CARTcell HT Dr. Jeffrey Zonder
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo 2024-05-30 01:12:41 Impact of extramedullary multiple myeloma [EMD] on outcomes with idecabtagene vicleucel - @ZanwarSaurabh et al. #ASCO24 Abstract 7508 meetings.asco.org/abstracts-pres… #mmsm #CARTcell HT @Amyloid_Planet Impact of extramedullary multiple myeloma [EMD] on outcomes with idecabtagene vicleucel - @ZanwarSaurabh et al. #ASCO24 Abstract 7508 meetings.asco.org/abstracts-pres… #mmsm #CARTcell HT @Amyloid_Planet](https://pbs.twimg.com/media/GOydN_zWUAASe7y.jpg)
![Dr. Jeffrey Zonder(@Amyloid_Planet) 's Twitter Profile Photo Dr. Jeffrey Zonder(@Amyloid_Planet) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/860371247045201920/YqnTch_C_200x200.jpg)
Cannot over-emphasize the importance of this. In the USA to optimize outcomes in #ATTR #amyloidosis therapy, this has to kept in mind at all times. Equal access to diagnostic testing, to SOC therapy, and to trials #ISA2024 The International Society Of Amyloidosis
![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
Myeloma / Plasma Cell Dyscrasia ~ #ASCO24 Top10 (or so) #mmsm #mmMRD #ASCO24 - Mike Thompson, MD, PhD, FASCO *DRAFT* Table Update: May 29, 2024 v2 - cc Surviving Myeloma Joseph Mikhael Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Rahul Banerjee, MD, FACP C. Ola Landgren, M.D. Meera Mohan Luciano J Costa @MyelomaTeacher - Cindy Chmielewski Keith Stockerl-Goldstein, MD 😷 Vincent Rajkumar Binod Dhakal
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo 2024-05-29 16:20:45 Myeloma / Plasma Cell Dyscrasia ~ #ASCO24Top10 (or so) #mmsm #mmMRD #ASCO24 - @mtmdphd *DRAFT* Table Update: May 29, 2024 v2 - cc @grpetersen1 @jmikhaelmd @szusmani @RahulBanerjeeMD @DrOlaLandgren @MeeraMohanMD @End_myeloma @MyelomaTeacher @CyclingDoctor @VincentRK @bhemato Myeloma / Plasma Cell Dyscrasia ~ #ASCO24Top10 (or so) #mmsm #mmMRD #ASCO24 - @mtmdphd *DRAFT* Table Update: May 29, 2024 v2 - cc @grpetersen1 @jmikhaelmd @szusmani @RahulBanerjeeMD @DrOlaLandgren @MeeraMohanMD @End_myeloma @MyelomaTeacher @CyclingDoctor @VincentRK @bhemato](https://pbs.twimg.com/media/GOwl2B4XMAgnutd.png)
![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
Top Influencers of #mmMRD [5/29/24; last 7d by SymplurRank]👉 Mike Thompson, MD, PhD, FASCO Joseph Mikhael Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Surviving Myeloma Rahul Banerjee, MD, FACP @MyelomaTeacher - Cindy Chmielewski Meera Mohan C. Ola Landgren, M.D. Keith Stockerl-Goldstein, MD 😷
Luciano J Costa hcsm.io/2SeYcGh via Symplur #mmsm
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo 2024-05-29 14:28:12 Top Influencers of #mmMRD [5/29/24; last 7d by SymplurRank]👉 @mtmdphd @jmikhaelmd @szusmani @grpetersen1 @RahulBanerjeeMD @MyelomaTeacher @MeeraMohanMD @DrOlaLandgren @CyclingDoctor @End_myeloma hcsm.io/2SeYcGh via @symplur #mmsm Top Influencers of #mmMRD [5/29/24; last 7d by SymplurRank]👉 @mtmdphd @jmikhaelmd @szusmani @grpetersen1 @RahulBanerjeeMD @MyelomaTeacher @MeeraMohanMD @DrOlaLandgren @CyclingDoctor @End_myeloma hcsm.io/2SeYcGh via @symplur #mmsm](https://pbs.twimg.com/media/GOwM0PdXYAAFoh8.jpg)
![Mandy Davis Aitken(@davisa20) 's Twitter Profile Photo Mandy Davis Aitken(@davisa20) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/880192893700505603/aHvFvK1-_200x200.jpg)
![Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰(@szusmani) 's Twitter Profile Photo Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰(@szusmani) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1474749700813340672/gCrBbMHb_200x200.jpg)
Congrats to our Myeloma Fellows Drs. Ross Firestone and Eric Jurgens for receiving the Conquer Cancer, the ASCO Foundation Young investigator Awards this year #ASCO24 #mmsm Memorial Sloan Kettering Cancer Center MSK Department of Medicine Neha Korde Urvi Shah Carlyn Tan Malin Hultcrantz MD PhD Sridevi Rajeeve, MD AlexanderLesokhin MD Hamza Hashmi
![Luciano J Costa(@End_myeloma) 's Twitter Profile Photo Luciano J Costa(@End_myeloma) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/950124810151059457/XpaAgzNJ_200x200.jpg)
![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP) - Ben Derman et al. Andrzej Jakubowiak #ASCO24 Abstract 106 meetings.asco.org/abstracts-pres… #NCT04108624 #mmsm #mmMRD
![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
A Historic Turning Point: ODAC Unanimously Votes [4/12/24] in Favor of MRD Testing as an Early Endpoint in Myeloma Clinical Trials to Support Accelerated Approvals of New Treatments [Apr 18, 2024] International Myeloma Foundation
myeloma.org/blog/dr-duries… #mmMRD #mmsm #ctsm FDA Oncology
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo 2024-05-29 14:12:46 A Historic Turning Point: ODAC Unanimously Votes [4/12/24] in Favor of MRD Testing as an Early Endpoint in Myeloma Clinical Trials to Support Accelerated Approvals of New Treatments [Apr 18, 2024] @IMFmyeloma myeloma.org/blog/dr-duries… #mmMRD #mmsm #ctsm @FDAOncology A Historic Turning Point: ODAC Unanimously Votes [4/12/24] in Favor of MRD Testing as an Early Endpoint in Myeloma Clinical Trials to Support Accelerated Approvals of New Treatments [Apr 18, 2024] @IMFmyeloma myeloma.org/blog/dr-duries… #mmMRD #mmsm #ctsm @FDAOncology](https://pbs.twimg.com/media/GOwJSdKXcAAwYaG.jpg)
![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma [Jul 11, 2022] Ben Derman Andrzej Jakubowiak Mike Thompson, MD, PhD, FASCO Blood Cancer Journal nature.com/articles/s4140… #mmMRD #mmsm #openaccess
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo 2024-05-29 14:12:29 Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma [Jul 11, 2022] @bdermanmd @ajjakubowiak @mtmdphd @BloodCancerJnl nature.com/articles/s4140… #mmMRD #mmsm #openaccess Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma [Jul 11, 2022] @bdermanmd @ajjakubowiak @mtmdphd @BloodCancerJnl nature.com/articles/s4140… #mmMRD #mmsm #openaccess](https://pbs.twimg.com/media/GOwJLX9XsAAFR1_.png)
![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] Ben Derman Jagoda Andrzej Jakubowiak Brit J Haematol ow.ly/3GSO50Cr8Mc #mmsm #mmMRD
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo 2024-05-29 14:11:54 Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] @bdermanmd @jagoda_jasielec @ajjakubowiak Brit J Haematol ow.ly/3GSO50Cr8Mc #mmsm #mmMRD Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] @bdermanmd @jagoda_jasielec @ajjakubowiak Brit J Haematol ow.ly/3GSO50Cr8Mc #mmsm #mmMRD](https://pbs.twimg.com/media/GOwJGhfX0AAdvle.png)
![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
#mmMRD healthcare social media hashtag [Nov 21, 2020] Minimal/measurable residual disease (MRD) in multiple myeloma. Submitted by Ben Derman to Symplur Healthcare Hashtag Project symplur.com/healthcare-has… #mmsm
![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
![Lynn M. Schuchter, MD, FASCO(@ASCOPres) 's Twitter Profile Photo Lynn M. Schuchter, MD, FASCO(@ASCOPres) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1665776832312930311/8e1GDxPK_200x200.png)
![Keith Stockerl-Goldstein, MD 😷(@CyclingDoctor) 's Twitter Profile Photo Keith Stockerl-Goldstein, MD 😷(@CyclingDoctor) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1754847566020120576/aInDcWcJ_200x200.jpg)
The rest of my top 10 #mmsm #ASCO24 abstracts Mike Thompson, MD, PhD, FASCO
In addition to #7572 Lessans-Cardiac transplant outcomes in AL and #7571 Liu-DM and MGUS progression
(in no particular order)
#bmtsm #celltherapy #cartcells #cellulartherapy
![Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo Mike Thompson, MD, PhD, FASCO(@mtmdphd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/939255143337410560/FDwij8zZ_200x200.jpg)
Myeloma / Plasma Cell Dyscrasia ~ #ASCO24 Top10 (or so) #mmsm #mmMRD #ASCO24 - Mike Thompson, MD, PhD, FASCO *DRAFT* Table Update: May 28, 2024 - cc Surviving Myeloma Joseph Mikhael Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Rahul Banerjee, MD, FACP C. Ola Landgren, M.D. Meera Mohan Luciano J Costa @MyelomaTeacher - Cindy Chmielewski Keith Stockerl-Goldstein, MD 😷
![Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo 2024-05-28 18:17:35 Myeloma / Plasma Cell Dyscrasia ~ #ASCO24Top10 (or so) #mmsm #mmMRD #ASCO24 - @mtmdphd *DRAFT* Table Update: May 28, 2024 - cc @grpetersen1 @jmikhaelmd @szusmani @RahulBanerjeeMD @DrOlaLandgren @MeeraMohanMD @End_myeloma @MyelomaTeacher @CyclingDoctor Myeloma / Plasma Cell Dyscrasia ~ #ASCO24Top10 (or so) #mmsm #mmMRD #ASCO24 - @mtmdphd *DRAFT* Table Update: May 28, 2024 - cc @grpetersen1 @jmikhaelmd @szusmani @RahulBanerjeeMD @DrOlaLandgren @MeeraMohanMD @End_myeloma @MyelomaTeacher @CyclingDoctor](https://pbs.twimg.com/media/GOr3BleWUAAf7pn.png)